Cite
APA Citation
Sellam, J., Rivière, E., Courties, A., Rouzaire, P., Tolusso, B., Vital, E., Emery, P., Ferracioli, G., Soubrier, M., Ly, B., Hendel Chavez, H., Taoufik, Y., Dougados, M., & Mariette, X. (2016). serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis research & therapy, 18(1), 1–8. http://access.bl.uk/ark:/81055/vdc_100081034816.0x00002a